Filing Details

Accession Number:
0001628280-24-050111
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-05 17:04:21
Reporting Period:
2024-11-01
Accepted Time:
2024-12-05 17:04:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1087294 Cumberland Pharmaceuticals Inc CPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490829 James Jones 1600 West End Avenue, Suite 1300
Nashville TN 37203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-01 76 $1.15 37,947 No 5 P Direct
Common Stock Acquisiton 2024-11-04 49 $1.17 37,996 No 5 P Direct
Common Stock Acquisiton 2024-11-05 76 $1.20 38,072 No 5 P Direct
Common Stock Acquisiton 2024-11-06 76 $1.20 38,148 No 5 P Direct
Common Stock Acquisiton 2024-11-07 76 $1.17 38,224 No 5 P Direct
Common Stock Acquisiton 2024-11-08 76 $1.18 38,300 No 5 P Direct
Common Stock Acquisiton 2024-11-11 76 $1.20 38,376 No 5 P Direct
Common Stock Acquisiton 2024-11-12 76 $1.20 38,452 No 5 P Direct
Common Stock Acquisiton 2024-11-13 76 $1.20 38,528 No 5 P Direct
Common Stock Acquisiton 2024-11-14 76 $1.19 38,604 No 5 P Direct
Common Stock Acquisiton 2024-11-15 76 $1.17 38,680 No 5 P Direct
Common Stock Acquisiton 2024-11-18 76 $1.18 38,756 No 5 P Direct
Common Stock Acquisiton 2024-11-19 76 $1.15 38,832 No 5 P Direct
Common Stock Acquisiton 2024-11-20 85 $1.13 38,917 No 5 P Direct
Common Stock Acquisiton 2024-11-21 85 $1.09 39,002 No 5 P Direct
Common Stock Acquisiton 2024-11-22 75 $1.07 39,077 No 5 P Direct
Common Stock Acquisiton 2024-11-25 75 $1.09 39,152 No 5 P Direct
Common Stock Acquisiton 2024-11-26 75 $1.11 39,227 No 5 P Direct
Common Stock Acquisiton 2024-11-27 75 $1.15 39,302 No 5 P Direct
Common Stock Acquisiton 2024-11-29 75 $1.32 39,377 No 5 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
No 5 P Direct
Footnotes
  1. The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024.